Roivant Sciences ROIV Ratios & Valuation
| Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | ||
|---|---|---|---|---|---|---|
| Efficiency | ||||||
| Asset turnover | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Liquidity | ||||||
| Current ratio | 18.4×-12.3× | 30.7×-3.0× | 33.7×-6.8× | 40.5×+7.1× | 33.5×-4.4× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $6.52+6.5% | $6.13-4.4% | $6.41+0.3% | $6.39-1.1% | $6.46-10.0% | |
| Valuation | ||||||
| Market capitalization | $19.82B+31.4% | $15.09B+46.1% | $10.33B+31.7% | $7.84B+9.0% | $7.2B-16.4% | |
| Price / sales | 2,400.1×+1,266× | 1,133.9×+626× | 508.2×+171× | 337.7×+89.9× | 247.8×-34.5× | |
| Price / book | 4.4×+0.8× | 3.5×+1.2× | 2.4×+0.6× | 1.8×+0.3× | 1.5×-0.1× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Roivant Sciences's ratios come from?
- Every ratio is computed from Roivant Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
